About 30% of people in the United States say they did not seek health care when it was needed because of many factors. By: All-American Health Organization (PAHO) To facilitate such access, it is necessary to take action with a multi-sectoral approach, thus encouraging the commitment of the whole society to contribute to the health and well-being of its inhabitants.
In this sense և within World Health DayPfizer experts agree on health promotion as a driver of recovery, especially in Latin America.
«The: medical advances and innovations they lose their meaning if they do not reach the patients who need them. “Consequently, all actors in society can work together to create innovative entry models that positively impact people’s quality of life,” said Pfizer, President of Latin America Carlos Murillo.
“At Pfizer, we know that welfare “Economic growth is closely linked to the health of the population. The more people have adequate health care coverage, the easier it will be to support recovery, especially in Latin America,” he said.
Access to health care is the key to prosperity and economic growth in Latin America
Health during an epidemic
two years after the start of the health emergency COVID-19:The United Nations notes that sound health systems and emergency preparedness are essential for communities and their economies. It should be noted that the end of the epidemic in 2020 caused a loss of up to $ 375 billion per month worldwide, but after this panorama, today the region is facing a different panorama, as it generally indicates growth rates. 2.4% in 2022
The Organization for Economic Co-operation and Development (OECD), in turn, emphasizes that: Economic recovery It will depend on countries being able to secure the resources to continue to deliver vaccines to their populations, so efforts require effective multilateral action to exchange knowledge, medical and financial resources.
The OECD itself states that: pandemic COVID-19 changed the way we think about our economies, our societies.
The OECD notes that the COVID-19 epidemic changed the way we think about our economies, our societies.
health through science
For Luis Arantes, medical director at Latin America Pfizer access to health It is crucial not only for the growth of economies, but also for the progress of science itself. “We are in a historic moment when, in record time, we are working on small-molecule drugs, large-molecule biotherapy, cell-gene therapy, as well as vaccine research, along with developing oral vaccine therapy. “RNA-based messenger,” says Pfizer’s doctor and director.
In this regard, մասին in particular about messenger RNA technology, the same is used for development Covid-1 vaccine9 Pfizer takes many steps և investing in the power of mRNA to unlock the full potential of this platform to provide life-changing advances for patients.
Arantes, on the other hand, sees the panorama medical advances “Our medical innovations, 25 of which are scheduled to arrive in Latin America by 2025, could mark a turning point in people’s lives, then a positive factor for their well-being and productivity. the region in general, ”concludes the medical leader of Pfizer LatAm.
Access to health care is not only crucial for economic growth, but also for the advancement of science itself.
Health within reach
Accelerate access to health և, consequently, promoteeconomic recoveryPfizer actively works with governments գործընկեր healthcare partners around the world to provide fair, equitable access to the treatments they need. An example of this is the voluntary licensing agreement for the production and distribution of oral antiviral medicine for the treatment of COVID-19, which was signed last November with the United Nations-backed Drug Enforcement Administration (MPP). works to increase access to vital medicines for low- and middle-income countries.
This is in addition to the efforts made through agreements that have a direct impact on the region, such as the one signed in 2021 between the Caribbean Community (CARICOM) and the United States Government to distribute doses of the COVID-19 vaccine. Pfizer և BioNTech: CARICOM in 15 member countries; In addition to COVAX’s direct involvement, the WHO-led Global Initiative, through the All-American Health Organization Revolving Fund, has already delivered hundreds of millions of COVID-19 vaccines from various Latin American pharmaceutical companies. Caribbean basin.
For Carlos Murillo, “these efforts were added to everyone local և regional initiatives “Companies, governments and organizations will play a key role in rebuilding Latin America in 2022.” The manager of Pfizer finally states that “all patients should have access to the medicines they need և health care. “We know this is an issue that requires the work and support of all actors in society, so we urge them to join forces to continue to prioritize health as a driver of regional recovery and growth.”